瑞丰高材：公司子公司瑞丰生物主要从事合成生物材料的开发

Core Viewpoint - Ruifeng High Materials' subsidiary, Ruifeng Bio, is engaged in the development of synthetic biomaterials, with a focus on products such as polylactic acid, succinic acid, and dextran, indicating a solid technical foundation in these areas [2] Group 1 - Ruifeng Bio has successfully commenced the external sales of dextran, actively exploring market opportunities, particularly for its use in animal iron supplements, dextran iron [2] - The company plans to expand dextran production capacity by 2026 and will continue to develop sales markets, although this expansion is not expected to have a significant short-term impact on performance [2] - Future strategies include expanding product categories through both in-house research and external technology collaborations, aiming for gradual large-scale implementation [2]